a promising nRNA vaccine against relapses
A personalized treatment based on messenger RNA has given good initial results in the treatment of this cancer. This is the review Nature which relays the results of a personalized vaccine based on messenger RNA and developed by BioNTech and Roche. It targets aggressive forms of pancreatic cancer. At the end of the first test … Read more